Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hellstern

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Haemostasis|January 1, 1985
Combined dys-form of homozygous factor XI deficiency and heterozygous factor XII deficiencyP Hellstern, C Mannhalter, M Köhler, et al.
Vox Sanguinis|February 22, 2002
Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgeryH Haubelt, M Blome, A H Kiessling, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 27, 2002
Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery diseaseR Zahn, H Beeck, B R Winkelmann, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Subcutaneous injection of desmopressin (DDAVP) for increasing factor VIII and von Willebrand factor in plasmapheresis]M Köhler, R Kotitschke, B Braun, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary riskJ Bach, G Endler, B R Winkelmann, et al.
Pharmacogenomics|March 22, 2001
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular diseaseB R Winkelmann, W März, B O Boehm, et al.
Blut|December 1, 1988
In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients. The influence of reagents and standardsM Köhler, E Seifried, P Hellstern, et al.
Drugs|January 1, 1987
Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findingsP Hellstern, P Doenecke, M Köhler, et al.
Klinische Wochenschrift|August 1, 1985
[Successful treatment of superior mesenteric artery thrombosis with local high-dose urokinase therapy]M Köhler, B Kramann, P Hellstern, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2007
Preservation of in vitro function of platelets stored in the presence of a synthetic dual inhibitor of factor Xa and thrombinP Hellstern, U Stürzebecher, B Wuchold, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Haemostasis|January 1, 1985
Combined dys-form of homozygous factor XI deficiency and heterozygous factor XII deficiencyP Hellstern, C Mannhalter, M Köhler, et al.
Vox Sanguinis|February 22, 2002
Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgeryH Haubelt, M Blome, A H Kiessling, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 27, 2002
Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery diseaseR Zahn, H Beeck, B R Winkelmann, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1990
[Subcutaneous injection of desmopressin (DDAVP) for increasing factor VIII and von Willebrand factor in plasmapheresis]M Köhler, R Kotitschke, B Braun, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary riskJ Bach, G Endler, B R Winkelmann, et al.
Pharmacogenomics|March 22, 2001
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular diseaseB R Winkelmann, W März, B O Boehm, et al.
Blut|December 1, 1988
In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients. The influence of reagents and standardsM Köhler, E Seifried, P Hellstern, et al.
Drugs|January 1, 1987
Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findingsP Hellstern, P Doenecke, M Köhler, et al.
Klinische Wochenschrift|August 1, 1985
[Successful treatment of superior mesenteric artery thrombosis with local high-dose urokinase therapy]M Köhler, B Kramann, P Hellstern, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2007
Preservation of in vitro function of platelets stored in the presence of a synthetic dual inhibitor of factor Xa and thrombinP Hellstern, U Stürzebecher, B Wuchold, et al.
Pageof 9